1. Home
  2. CSV vs ANL Comparison

CSV vs ANL Comparison

Compare CSV & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carriage Services Inc.

CSV

Carriage Services Inc.

HOLD

Current Price

$37.88

Market Cap

643.0M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.09

Market Cap

611.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSV
ANL
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
643.0M
611.1M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
CSV
ANL
Price
$37.88
$10.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$59.00
$20.00
AVG Volume (30 Days)
125.5K
176.5K
Earning Date
05-06-2026
04-10-2026
Dividend Yield
0.92%
N/A
EPS Growth
54.76
N/A
EPS
0.84
N/A
Revenue
$417,440,000.00
N/A
Revenue This Year
$7.35
$36.02
Revenue Next Year
$3.87
N/A
P/E Ratio
$45.32
N/A
Revenue Growth
3.28
N/A
52 Week Low
$37.11
$0.88
52 Week High
$52.10
$17.25

Technical Indicators

Market Signals
Indicator
CSV
ANL
Relative Strength Index (RSI) 41.74 44.82
Support Level $37.13 $9.00
Resistance Level $44.62 $9.98
Average True Range (ATR) 1.13 1.41
MACD 0.17 0.03
Stochastic Oscillator 28.42 40.46

Price Performance

Historical Comparison
CSV
ANL

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: